Results
|
2021.
|
|
|
2022.
|
|
|
2023.
|
|
|
2024.
|
|
|
2025.
|
Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I. [electronic resource] by
- Gontarewicz, Artur
- Balabanov, Stefan
- Keller, Gunhild
- Colombo, Riccardo
- Graziano, Alessio
- Pesenti, Enrico
- Benten, Daniel
- Bokemeyer, Carsten
- Fiedler, Walter
- Moll, Jürgen
- Brümmendorf, Tim H
Producer: 20080513
In:
Blood vol. 111
Availability: No items available.
|
|
2026.
|
|
|
2027.
|
Aurora kinase inhibition overcomes cetuximab resistance in squamous cell cancer of the head and neck. [electronic resource] by
- Hoellein, Alexander
- Pickhard, Anja
- von Keitz, Fabienne
- Schoeffmann, Stephanie
- Piontek, Guido
- Rudelius, Martina
- Baumgart, Anja
- Wagenpfeil, Stefan
- Peschel, Christian
- Dechow, Tobias
- Bier, Henning
- Keller, Ulrich
Producer: 20120123
In:
Oncotarget vol. 2
Availability: No items available.
|
|
2028.
|
The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells. [electronic resource] by
- Sehdev, Vikas
- Peng, DunFa
- Soutto, Mohammed
- Washington, M Kay
- Revetta, Frank
- Ecsedy, Jeffrey
- Zaika, Alexander
- Rau, Tilman T
- Schneider-Stock, Regine
- Belkhiri, Abbes
- El-Rifai, Wael
Producer: 20120709
In:
Molecular cancer therapeutics vol. 11
Availability: No items available.
|
|
2029.
|
|
|
2030.
|
Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase families. [electronic resource] by
- Glaser, Keith B
- Li, Junling
- Marcotte, Patrick A
- Magoc, Terrance J
- Guo, Jun
- Reuter, David R
- Tapang, Paul
- Wei, Ru-Qi
- Pease, Lori J
- Bui, Mai H
- Chen, Zehan
- Frey, Robin R
- Johnson, Eric F
- Osterling, Donald J
- Olson, Amanda M
- Bouska, Jennifer J
- Luo, Yanping
- Curtin, Michael L
- Donawho, Cherrie K
- Michaelides, Michael R
- Tse, Chris
- Davidsen, Steven K
- Albert, Daniel H
Producer: 20130124
In:
The Journal of pharmacology and experimental therapeutics vol. 343
Availability: No items available.
|
|
2031.
|
Predictive biomarkers of sensitivity to the aurora and angiogenic kinase inhibitor ENMD-2076 in preclinical breast cancer models. [electronic resource] by
- Diamond, Jennifer R
- Eckhardt, S Gail
- Tan, Aik Choon
- Newton, Timothy P
- Selby, Heather M
- Brunkow, Kelsey L
- Kachaeva, Maria I
- Varella-Garcia, Marileila
- Pitts, Todd M
- Bray, Mark R
- Fletcher, Graham C
- Tentler, John J
Producer: 20130618
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 19
Availability: No items available.
|
|
2032.
|
|
|
2033.
|
|
|
2034.
|
Imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases: lead optimization studies toward the identification of an orally bioavailable preclinical development candidate. [electronic resource] by
- Bavetsias, Vassilios
- Large, Jonathan M
- Sun, Chongbo
- Bouloc, Nathalie
- Kosmopoulou, Magda
- Matteucci, Mizio
- Wilsher, Nicola E
- Martins, Vanessa
- Reynisson, Jóhannes
- Atrash, Butrus
- Faisal, Amir
- Urban, Frederique
- Valenti, Melanie
- de Haven Brandon, Alexis
- Box, Gary
- Raynaud, Florence I
- Workman, Paul
- Eccles, Suzanne A
- Bayliss, Richard
- Blagg, Julian
- Linardopoulos, Spiros
- McDonald, Edward
Producer: 20100825
In:
Journal of medicinal chemistry vol. 53
Availability: No items available.
|
|
2035.
|
|
|
2036.
|
|
|
2037.
|
Identification of V23RalA-Ser194 as a critical mediator for Aurora-A-induced cellular motility and transformation by small pool expression screening. [electronic resource] by
- Wu, Jiunn-Chyi
- Chen, Tzong-Yueh
- Yu, Chang-Tze R
- Tsai, Si-Jie
- Hsu, Jung-Mao
- Tang, Ming-Jer
- Chou, Chen-Kung
- Lin, Wey-Jinq
- Yuan, Chiun-Jye
- Huang, Chi-Ying F
Producer: 20050419
In:
The Journal of biological chemistry vol. 280
Availability: No items available.
|
|
2038.
|
|
|
2039.
|
|
|
2040.
|
|